ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

FDA Rescinds Marketing Denial Order for Humble’s Flavored E-liquids

November 5, 2021 GMT
Humble Juice Co. (PRNewsfoto/Humble Juice Co.)
Humble Juice Co. (PRNewsfoto/Humble Juice Co.)
Humble Juice Co. (PRNewsfoto/Humble Juice Co.)

THOUSAND OAKS, Calif., Nov. 5, 2021 /PRNewswire/ -- Humble Juice Co., a leading e-liquid company with a humble beginning, announced today that the U.S. Food and Drug Administration (FDA) has rescinded the marketing denial order (MDO) issued Sept. 15, 2021 for Humble’s flavored e-liquid products with pending Premarket Tobacco Product Applications (PMTAs).

Humble had filed a petition in October with the U.S. Court of Appeals for the Ninth Circuit, challenging the FDA’s decision and seeking to have the MDO vacated. Following the receipt of the rescission letter, Humble withdrew its petition as FDA’s rescission of Humble’s MDO places the brand’s flavored e-liquids back into the PMTA review process and provides Humble with a pathway to market its products while its PMTAs are pending.

FDA’s rescission letter states that upon further review it identified information contained in Humble’s PMTA that requires additional evaluation such as “randomized controlled trials comparing tobacco-flavored ENDS to flavored ENDS as well as several cross-sectional surveys evaluating intentions to use or likelihood of use in current smokers, current ENDS users, former tobacco users, and never users.” The agency also stated that due to the unusual circumstances, it “has no intention of initiating an enforcement action” against any of Humble’s flavored e-liquid products with pending PMTAs. Humble will continue to market its products while its application remains in the review process.

ADVERTISEMENT

“FDA’s decision to rescind the MDO re-instills our faith in this challenging but science-based regulatory process,” said Humble CEO Daniel Clark. “We remain confident in and proud of our extensive PMTA submission. We are committed to working with the FDA to obtain marketing orders for the products submitted in our initial PMTAs in order to provide Humble’s adult consumers with flavor-filled and affordable e-juice long into the future.”

About Humble Juice Co.
Founded in 2015 by Daniel Clark, the Southern California-based company, was born from a single idea: Hardworking, honest people can make high-quality vape e-juice at an affordable price. That humble goal has resulted in the brand’s demand both domestically and internationally, a robust e-commerce and retailer presence, and a thriving innovation pipeline.

Humble is committed to producing flavor-filled and complaint e-juice, and is currently undergoing the Premarket Tobacco Product Application process with the U.S. Food and Drug Administration.

To learn more about Humble, visit www.humblejuiceco.com.

View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-rescinds-marketing-denial-order-for-humbles-flavored-e-liquids-301417816.html

SOURCE Humble Juice Co.